MRSN
Price
$9.78
Change
-$0.04 (-0.41%)
Updated
Oct 24 closing price
Capitalization
48.81M
15 days until earnings call
Intraday Buy/Sell Signals
RPTX
Price
$1.96
Change
+$0.03 (+1.55%)
Updated
Oct 24 closing price
Capitalization
84.2M
10 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

MRSN vs RPTX

Header iconMRSN vs RPTX Comparison
Open Charts MRSN vs RPTXBanner chart's image
Mersana Therapeutics
Price$9.78
Change-$0.04 (-0.41%)
Volume$30.49K
Capitalization48.81M
Repare Therapeutics
Price$1.96
Change+$0.03 (+1.55%)
Volume$208.21K
Capitalization84.2M
MRSN vs RPTX Comparison Chart in %
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MRSN vs. RPTX commentary
Oct 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRSN is a Hold and RPTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 27, 2025
Stock price -- (MRSN: $9.78 vs. RPTX: $1.96)
Brand notoriety: MRSN and RPTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MRSN: 48% vs. RPTX: 158%
Market capitalization -- MRSN: $48.81M vs. RPTX: $84.2M
MRSN [@Biotechnology] is valued at $48.81M. RPTX’s [@Biotechnology] market capitalization is $84.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $108.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRSN’s FA Score shows that 0 FA rating(s) are green whileRPTX’s FA Score has 0 green FA rating(s).

  • MRSN’s FA Score: 0 green, 5 red.
  • RPTX’s FA Score: 0 green, 5 red.
According to our system of comparison, RPTX is a better buy in the long-term than MRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRSN’s TA Score shows that 5 TA indicator(s) are bullish while RPTX’s TA Score has 4 bullish TA indicator(s).

  • MRSN’s TA Score: 5 bullish, 5 bearish.
  • RPTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both MRSN and RPTX are a good buy in the short-term.

Price Growth

MRSN (@Biotechnology) experienced а -1.01% price change this week, while RPTX (@Biotechnology) price change was +7.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.97%. For the same industry, the average monthly price growth was +11.13%, and the average quarterly price growth was +63.98%.

Reported Earning Dates

MRSN is expected to report earnings on Nov 11, 2025.

RPTX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+0.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RPTX($84.2M) has a higher market cap than MRSN($48.8M). RPTX YTD gains are higher at: 49.618 vs. MRSN (-72.643). MRSN has higher annual earnings (EBITDA): -68.88M vs. RPTX (-110.47M). RPTX has more cash in the bank: 109M vs. MRSN (77M). RPTX has less debt than MRSN: RPTX (649K) vs MRSN (20.6M). MRSN has higher revenues than RPTX: MRSN (34.8M) vs RPTX (250K).
MRSNRPTXMRSN / RPTX
Capitalization48.8M84.2M58%
EBITDA-68.88M-110.47M62%
Gain YTD-72.64349.618-146%
P/E RatioN/AN/A-
Revenue34.8M250K13,920%
Total Cash77M109M71%
Total Debt20.6M649K3,174%
FUNDAMENTALS RATINGS
MRSN: Fundamental Ratings
MRSN
OUTLOOK RATING
1..100
45
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MRSNRPTX
RSI
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 10 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OMTK0.01N/A
+4.86%
Omnitek Engineering Corp.
JHIUF21.49N/A
N/A
James Hardie Industries plc
PLXNF17.35N/A
N/A
PLUXEE N V
AFNL190.51N/A
N/A
Amfin Financial Corp.
AMNF10.09-0.06
-0.58%
Armanino Foods of Distinction, Inc.

RPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with BCYC. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then BCYC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPTX
1D Price
Change %
RPTX100%
+1.55%
BCYC - RPTX
54%
Loosely correlated
+0.90%
INO - RPTX
51%
Loosely correlated
+3.56%
CADL - RPTX
42%
Loosely correlated
+1.69%
ALNY - RPTX
38%
Loosely correlated
-0.12%
AXON - RPTX
37%
Loosely correlated
+2.73%
More